美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Definium Therapeutics

17.62

+0.17000.97%

成交量：115.84萬

成交額：2,035.73萬

市值：17.36億

市盈率：-8.92

高：17.85

開：17.62

低：17.35

收：17.45

52周最高：18.70

52周最低：4.70

股本：9,850.93萬

流通股本：9,133.48萬

量比：1.18

換手率：1.27%

股息：- -

股息率：- -

每股收益(TTM):-1.9758

每股收益(LYR):-1.5424

淨資產收益率：-85.59%

總資產收益率：-33.95%

市淨率：13.29

市盈率(LYR):-11.42

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Definium Therapeutics

交易所：

NASDAQ

成立時間：

2019

員工人數：

74

公司地址：

One World Trade Center,Suite 8500,New York,New York,United States

官網：

http://www.definiumtx.com

郵編：

10007

電話：

傳真：

- -

簡介：

Definium Therapeutics, Inc.在加拿大註冊成立。他們是一家臨床階段的神經藥物開發公司，通過嚴格的科學和臨床試驗，基於迷幻藥物開發候選產品。他們的任務是發現，開發和部署受迷幻藥啟發的藥物和療法，以治療精神病學，神經病學，成癮，疼痛以及潛在的其他疾病，如焦慮症，藥物濫用和戒斷以及成人注意力缺陷症。

董事

名稱

職位

Robert Barrow

Chief Executive Officer and Director

Carol A. Vallone

Chair of the Board

Andreas Krebs

Director

David Gryska

Director

Roger Adsett

Director

Roger Crystal

Director

Suzanne Bruhn

Director

股東

名稱

職位

Robert Barrow

Chief Executive Officer and Director

Brandi L. Roberts

Chief Financial Officer and Principal Accounting Officer

Carrie F. Liao

Chief Accounting Officer

Daniel Karlin

Chief Medical Officer

Mark Sullivan

Chief Legal Officer and Corporate Secretary

Matt Wiley

Chief Commercial Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/DFTX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":17.62,"timestamp":1772053200000,"preClose":17.45,"halted":0,"volume":1158406,"delay":0,"changeRate":0.009742120343839639,"floatShares":91334800,"shares":98509279,"eps":-1.975783,"marketStatus":"盤前交易","change":0.17,"latestTime":"02-26 04:12:47 EST","open":17.62,"high":17.85,"low":17.3507,"amount":20357305.7613,"amplitude":0.028613,"askPrice":19.06,"askSize":100,"bidPrice":15.31,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.975783,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1772116200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":17.62,"postHourTrading":{"tag":"盘后","latestPrice":17.438,"preClose":17.62,"latestTime":"19:31 EST","volume":41680,"amount":734364.0593,"timestamp":1772065899540,"change":-0.182,"changeRate":-0.010329,"amplitude":0.01903},"volumeRatio":1.1842686080785876,"impliedVol":0.7123,"impliedVolPercentile":0.1111},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":91334800,"roa":"-33.95%","roe":"-85.59%","lyrEps":-1.542397,"volumeRatio":1.1842686080785876,"shares":98509279,"dividePrice":0,"high":17.85,"amplitude":0.028613,"preClose":17.45,"low":17.3507,"week52Low":4.7,"pbRate":"13.29","week52High":18.7,"institutionHeld":0,"latestPrice":17.62,"eps":-1.975783,"divideRate":0,"volume":1158406,"delay":0,"ttmEps":-1.975783,"open":17.62,"prevYearClose":13.39,"prevWeekClose":17.13,"prevMonthClose":16.88,"prevQuarterClose":13.39,"fiveDayClose":17.38,"twentyDayClose":17.48,"sixtyDayClose":12.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"date":"2026-02-26","symbol":"DFTX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"defaultRemindTime":1772139600000,"name":null,"time":"盤後","dateTimestamp":1772082000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":15,"updateTime":1770094800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-02-24","current":-8.917983,"percent":0.538462,"low":-10.683198,"twenty":-10.176874,"median":-9.944809,"eighty":-9.553345,"high":-8.802064,"avg":-9.868843,"sd":0.453083,"marketCap":1669732279},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-24","current":-9.933088,"twenty":-10.176874,"median":-9.944809,"eighty":-9.553345,"marketCap":1669732279}],"updateTime":1772097167790},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":631045282,"yearFounded":2019,"employeeNum":74,"address":"One World Trade Center,Suite 8500,New York,New York,United States","zipCode":"10007","officePhone":"212 220 6633"},"stockCompanyDetail":{"websiteUrl":"http://www.definiumtx.com","stockEarnings":[{"period":"1week","weight":0.0138},{"period":"1month","weight":0.0672},{"period":"3month","weight":0.4562},{"period":"6month","weight":0.9842},{"period":"1year","weight":1.6104},{"period":"ytd","weight":0.3159}],"compareEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0198},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.0165}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Definium Therapeutics, Inc.在加拿大註冊成立。他們是一家臨床階段的神經藥物開發公司，通過嚴格的科學和臨床試驗，基於迷幻藥物開發候選產品。他們的任務是發現，開發和部署受迷幻藥啟發的藥物和療法，以治療精神病學，神經病學，成癮，疼痛以及潛在的其他疾病，如焦慮症，藥物濫用和戒斷以及成人注意力缺陷症。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.130491},{"month":2,"riseRate":0.8,"avgChangeRate":0.138859},{"month":3,"riseRate":0.25,"avgChangeRate":0.069329},{"month":4,"riseRate":0.75,"avgChangeRate":0.007711},{"month":5,"riseRate":0.4,"avgChangeRate":-0.002468},{"month":6,"riseRate":0.4,"avgChangeRate":-0.111207},{"month":7,"riseRate":0.8,"avgChangeRate":0.20763},{"month":8,"riseRate":0.2,"avgChangeRate":-0.091548},{"month":9,"riseRate":0.2,"avgChangeRate":-0.174855},{"month":10,"riseRate":0.6,"avgChangeRate":0.009639},{"month":11,"riseRate":0.4,"avgChangeRate":0.026551},{"month":12,"riseRate":0.4,"avgChangeRate":-0.08416}],"exchange":"NASDAQ","name":"Definium Therapeutics","nameEN":"Definium Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":{"directors":[{"name":"Robert Barrow","position":"Chief Executive Officer and Director"},{"name":"Carol A. Vallone","position":"Chair of the Board"},{"name":"Andreas Krebs","position":"Director"},{"name":"David Gryska","position":"Director"},{"name":"Roger Adsett","position":"Director"},{"name":"Roger Crystal","position":"Director"},{"name":"Suzanne Bruhn","position":"Director"}],"executives":[{"name":"Robert Barrow","position":"Chief Executive Officer and Director"},{"name":"Brandi L. Roberts","position":"Chief Financial Officer and Principal Accounting Officer"},{"name":"Carrie F. Liao","position":"Chief Accounting Officer"},{"name":"Daniel Karlin","position":"Chief Medical Officer"},{"name":"Mark Sullivan","position":"Chief Legal Officer and Corporate Secretary"},{"name":"Matt Wiley","position":"Chief Commercial Officer"}]}}}